BG25094A3 - A method of obtaining substituted purines - Google Patents

A method of obtaining substituted purines

Info

Publication number
BG25094A3
BG25094A3 BG7500032818A BG3281875A BG25094A3 BG 25094 A3 BG25094 A3 BG 25094A3 BG 7500032818 A BG7500032818 A BG 7500032818A BG 3281875 A BG3281875 A BG 3281875A BG 25094 A3 BG25094 A3 BG 25094A3
Authority
BG
Bulgaria
Prior art keywords
substituted purines
obtaining substituted
obtaining
purines
substituted
Prior art date
Application number
BG7500032818A
Other languages
Bulgarian (bg)
English (en)
Inventor
Schaeffer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10402412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG25094(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BG25094A3 publication Critical patent/BG25094A3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
BG7500032818A 1974-09-02 1975-09-02 A method of obtaining substituted purines BG25094A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38278/74A GB1523865A (en) 1974-09-02 1974-09-02 Purine compunds and salts thereof

Publications (1)

Publication Number Publication Date
BG25094A3 true BG25094A3 (en) 1978-07-12

Family

ID=10402412

Family Applications (4)

Application Number Title Priority Date Filing Date
BG7532817A BG26536A4 (fr) 1974-09-02 1975-09-02
BG7500032819A BG24815A3 (en) 1974-09-02 1975-09-02 Method of obtaining substituted purines
BG7500032818A BG25094A3 (en) 1974-09-02 1975-09-02 A method of obtaining substituted purines
BG7530910A BG26389A3 (fr) 1974-09-02 1975-09-02

Family Applications Before (2)

Application Number Title Priority Date Filing Date
BG7532817A BG26536A4 (fr) 1974-09-02 1975-09-02
BG7500032819A BG24815A3 (en) 1974-09-02 1975-09-02 Method of obtaining substituted purines

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG7530910A BG26389A3 (fr) 1974-09-02 1975-09-02

Country Status (35)

Country Link
US (3) US4294831A (fr)
JP (1) JPS5154589A (fr)
AR (4) AR220299A1 (fr)
AT (1) AT354462B (fr)
AU (1) AU503160B2 (fr)
BE (1) BE833006A (fr)
BG (4) BG26536A4 (fr)
CA (1) CA1062257A (fr)
CH (7) CH626363A5 (fr)
CS (2) CS203092B2 (fr)
CY (1) CY1033A (fr)
DD (1) DD122092A5 (fr)
DE (1) DE2539963A1 (fr)
DK (1) DK146595C (fr)
ES (3) ES440631A1 (fr)
FI (1) FI60709C (fr)
FR (1) FR2282892A1 (fr)
GB (1) GB1523865A (fr)
HK (1) HK84379A (fr)
HU (1) HU176730B (fr)
IE (1) IE42282B1 (fr)
IL (1) IL48035A (fr)
KE (1) KE3002A (fr)
LU (1) LU73304A1 (fr)
MC (1) MC1068A1 (fr)
MY (1) MY8200191A (fr)
NL (1) NL175061C (fr)
NO (1) NO144216C (fr)
NZ (1) NZ178556A (fr)
RO (4) RO74274A (fr)
SE (1) SE428562C (fr)
SU (7) SU904523A3 (fr)
YU (4) YU39947B (fr)
ZA (1) ZA755574B (fr)
ZM (1) ZM12875A1 (fr)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146715A (en) 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4287188A (en) 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
AU521577B2 (en) * 1977-02-24 1982-04-22 Wellcome Foundation Limited, The 9-hydroxyethoxymethyl guanine phosphates
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
JPS57102818A (en) * 1980-10-15 1982-06-26 Wellcome Found Treatment for fish virus diseases
US4603219A (en) * 1981-05-21 1986-07-29 Syntex (U.S.A.) Inc. 1,3-dibenzyloxy-2-acetoxymethoxypropane, intermediate for 9-(1,3-dihydroxy-2-propoxymethyl)guanine
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
GB2104070B (en) * 1981-08-11 1985-08-14 Wellcome Found Purines
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
JPS59500317A (ja) * 1982-02-12 1984-03-01 シンテツクス　（ユー・エス・エイ）　インコーポレイテツド 抗ウイルス性組成物
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
US5059604A (en) * 1982-10-14 1991-10-22 Burroughs Wellcome Co. 2-amino purine derivatives
FI74468C (fi) * 1982-10-14 1988-02-08 Wellcome Found Foerfarande foer framstaellning av terapeutiskt aktiva 2-aminopurinderivat.
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4745119A (en) * 1982-10-14 1988-05-17 Burroughs Wellcome Co. Method for using purine derivatives
US4649140A (en) * 1982-10-14 1987-03-10 Burroughs Wellcome Co. Purine derivatives
US4612314A (en) * 1982-12-22 1986-09-16 Syntex (U.S.A.) Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
ES520140A0 (es) * 1983-02-25 1984-04-01 Ind Farma Especial Un procedimiento para la preparacion de acicloguanosina.
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
ZA844744B (en) * 1983-06-24 1986-02-26 Merck & Co Inc Antiviral agents
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
US4918219A (en) * 1983-10-31 1990-04-17 Warner-Lambert Company Glycerine derivatives
ZA848080B (en) * 1983-10-31 1985-06-26 Warner Lambert Co Purine derivatives
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
DK163985A (da) * 1984-04-13 1985-10-14 Wellcome Found Antivirale purinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
EP0167385B1 (fr) 1984-07-03 1992-03-18 The Wellcome Foundation Limited Composés antiviraux, traitement et formulations
WO1986000901A1 (fr) * 1984-07-20 1986-02-13 Gauntt Charles O Compose immunoregulateur et anti-viral
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US5683990A (en) * 1985-03-16 1997-11-04 Glaxo Wellcome Inc. Treatment of human viral infections
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
EP0203736B1 (fr) 1985-05-02 1989-11-23 The Wellcome Foundation Limited Composés antiviraux
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
NZ222051A (en) * 1986-10-06 1990-07-26 Univ Virginia Solution containing adenosine or hypoxanthine and optionally ribose for heart protection during surgery
WO1988003923A1 (fr) * 1986-11-25 1988-06-02 Institut Organicheskogo Sinteza Akademii Nauk Latv Guanines substitutees en position 9
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US6306647B1 (en) 1987-06-16 2001-10-23 Ajinomoto Co., Inc. Process for producing and purifying 2′,3′-dideoxynucleosides, and process for producing 2′,3′-dideoxy-2′,3′-didehydronucleosides
US4835104A (en) * 1987-06-16 1989-05-30 Ajinomoto Co., Inc., Patent & Licensing Department Process for producing and purifying 2',3'-dideoxynucleosides, and process for producing 2',3'-dideoxy-2',3'-didehydronucleosides
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
GB8725939D0 (en) * 1987-11-05 1987-12-09 Wellcome Found Therapeutic compounds
CA1302887C (fr) * 1987-11-24 1992-06-09 Yves Langelier Melange d'acyclovir (ou d'un de ses devises) et de bacitracine
JPH01121424U (fr) * 1988-02-10 1989-08-17
US5164395A (en) * 1988-06-27 1992-11-17 Burroughs Wellcome Co. Antiviral acetyl pyridine derivative or said acetyl pyridine derivative in combination with acyclovir
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
JPH02164881A (ja) * 1988-10-24 1990-06-25 Wellcome Found Ltd:The 治療用ヌクレオシド化合物
KR910700253A (ko) * 1989-01-31 1991-03-14 로버트 제이, 바란 N_6-치환-9-메틸아데닌: 신규한 부류의 아데노신 수용체 길항질
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
GB8907173D0 (en) * 1989-03-30 1989-05-10 Beecham Group Plc Novel compounds
GB8912043D0 (en) * 1989-05-25 1989-07-12 Beecham Group Plc Novel compounds
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
CA2033447C (fr) * 1990-12-31 1999-08-31 Robert Deziel Complexe synergique pour le traitement des infections herpetiques
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
CA2091732C (fr) * 1992-07-08 1998-07-21 Anica Markovac Procede pour la preparation de 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenine
DK169121B1 (da) 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE59310344D1 (de) * 1992-09-24 2003-07-24 Hoechst Ag N1-Substituierte 1H-1,2,3-Triazolo[4,5-d]pyrimidine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
IT1264599B1 (it) * 1993-06-14 1996-10-04 Solar Chem Sa Processo per la sintesi della 9-(2-idrossietossimetil)- guanina
US5567816A (en) * 1994-07-26 1996-10-22 Syntex (U.S.A.) Inc. Preparation of acyclovir using 1,3 dioxolane
US5840891A (en) * 1994-07-28 1998-11-24 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) * 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
IN179493B (fr) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
US5789589A (en) * 1996-04-22 1998-08-04 Drug Innovation & Design, Inc. Guanine analog phosphates
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6180790B1 (en) 1997-05-15 2001-01-30 Drug Innovation And Design, Inc. Methods of preparing acyclovir prodrugs
WO1998051692A1 (fr) 1997-05-15 1998-11-19 Drug Innovation & Design, Inc. Derives diesters d'acyclovir
CA2421026C (fr) * 2001-10-16 2005-02-15 Avanir Pharmaceuticals Inhibition virale par le n-docosanol
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
JP4397691B2 (ja) * 2001-10-30 2010-01-13 コンフォーマ・セラピューティクス・コーポレイション Ｈｓｐ９０阻害活性を有するプリン類似体
US7078524B2 (en) 2002-11-22 2006-07-18 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
CN105596356A (zh) 2003-01-14 2016-05-25 吉里德科学公司 用于联合抗病毒治疗的组合物和方法
US20040200730A1 (en) * 2003-04-14 2004-10-14 Kyo Jibiki Hydrometallurgical copper recovery process
CN1968699B (zh) 2004-05-19 2010-12-15 爱密斯菲尔科技公司 阿昔洛韦制剂
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
US20090203636A1 (en) * 2006-03-14 2009-08-13 Bondarev Igor E Prevention and Treatment of Cancer and Other Diseases
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
EP2671888A1 (fr) 2008-12-23 2013-12-11 Gilead Pharmasset LLC Analogues de nucléoside phosphates 3',5'-cycliques
EA201100851A1 (ru) 2008-12-23 2012-04-30 Фармассет, Инк. Аналоги нуклеозидов
MX2011006891A (es) 2008-12-23 2011-10-06 Pharmasset Inc Fosforamidatos de nucleosidos.
EP2552931B1 (fr) 2010-03-31 2014-07-23 Gilead Pharmasset LLC Synthèse stéréosélective d'agents actifs contenant du phosphore
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions
WO2021209563A1 (fr) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Composés destinés à être utilisés dans le traitement d'infections virales par un coronavirus associé au syndrome respiratoire

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines

Also Published As

Publication number Publication date
CS203092B2 (en) 1981-02-27
FR2282892B1 (fr) 1980-04-25
AU503160B2 (en) 1979-08-23
US4360522A (en) 1982-11-23
GB1523865A (en) 1978-09-06
CH626364A5 (fr) 1981-11-13
SU904523A3 (ru) 1982-02-07
MC1068A1 (fr) 1976-05-21
DD122092A5 (fr) 1976-09-12
SU858569A3 (ru) 1981-08-23
DK392675A (da) 1976-03-03
SU686618A3 (ru) 1979-09-15
NL175061B (nl) 1984-04-16
CH629206A5 (de) 1982-04-15
NL175061C (nl) 1984-09-17
ZA755574B (en) 1977-04-27
CS203093B2 (en) 1981-02-27
AR220299A1 (es) 1980-10-31
BE833006A (fr) 1976-03-02
NO753009L (fr) 1976-03-03
CH629805A5 (de) 1982-05-14
MY8200191A (en) 1982-12-31
RO74275A (fr) 1981-09-24
CH626363A5 (fr) 1981-11-13
SU799664A3 (ru) 1981-01-23
ES455979A1 (es) 1978-01-16
BG24815A3 (en) 1978-05-12
NZ178556A (en) 1978-09-25
FR2282892A1 (fr) 1976-03-26
YU120182A (en) 1982-08-31
CY1033A (en) 1980-08-01
YU40080B (en) 1985-06-30
SE428562C (sv) 1985-08-20
AU8445975A (en) 1977-03-10
NO144216B (no) 1981-04-06
CA1062257A (fr) 1979-09-11
AT354462B (de) 1979-01-10
US4294831A (en) 1981-10-13
SU751325A3 (ru) 1980-07-23
NO144216C (no) 1981-07-15
HK84379A (en) 1979-12-14
AR220885A1 (es) 1980-12-15
BG26389A3 (fr) 1979-03-15
DE2539963A1 (de) 1976-03-18
HU176730B (en) 1981-04-28
SU784777A3 (ru) 1980-11-30
FI60709B (fi) 1981-11-30
ES455978A1 (es) 1978-01-16
AR212914A1 (es) 1978-11-15
ATA676375A (de) 1979-06-15
ZM12875A1 (en) 1977-09-21
FI752465A (fr) 1976-03-03
RO74276A (fr) 1981-06-26
NL7510342A (nl) 1976-03-04
CH623586A5 (fr) 1981-06-15
KE3002A (en) 1979-12-14
IL48035A0 (en) 1975-11-25
YU120082A (en) 1982-08-31
YU222075A (en) 1982-08-31
IE42282B1 (en) 1980-07-16
RO74274A (fr) 1981-09-24
YU39947B (en) 1985-06-30
RO76939A (fr) 1981-06-22
ES440631A1 (es) 1977-06-16
CH628897A5 (de) 1982-03-31
AR220508A1 (es) 1980-11-14
SU700064A3 (ru) 1979-11-25
US4323573A (en) 1982-04-06
SE7509675L (sv) 1976-03-03
LU73304A1 (fr) 1976-08-13
IL48035A (en) 1981-07-31
YU40079B (en) 1985-06-30
YU119982A (en) 1982-08-31
DK146595B (da) 1983-11-14
IE42282L (en) 1976-03-02
DK146595C (da) 1984-04-24
CH623587A5 (fr) 1981-06-15
DE2539963C2 (fr) 1987-01-22
BG26536A4 (fr) 1979-04-12
FI60709C (fi) 1982-03-10
SE428562B (sv) 1983-07-11
JPS5154589A (en) 1976-05-13
JPS6147839B2 (fr) 1986-10-21

Similar Documents

Publication Publication Date Title
BG25094A3 (en) A method of obtaining substituted purines
JPS53101385A (en) Method of producing phenyllpyrimidine
BG27744A3 (en) Method of obtaining of hynazolin derivatives
CS188985B2 (en) Method of producing aryl-1-azolylmethanes
BG24812A3 (en) Method of obtaining 8-thiomethylergolins
BG31223A3 (en) Method for obtaining of tertiarj olephines
BG25082A3 (en) A method of obtaining 1-aroyl-2-arylamine-2-imidazole derivatives
BG25074A3 (en) A method of obtaining substituted perhaloalkylamidines
BG24542A3 (en) Method of preparing carbonylaldiminomethanphosphonates
CS191882B2 (en) Method of preparing 7-methoxy-6-thia-tetracycline
ZA753873B (en) A method of preparing plaster
BG24807A3 (en) Method of obtaining pyridobenzodiazepinones
BG29427A3 (en) Method for obtaining of l- 6- dioxy- 5- hudroxytetracycline
BG25513A3 (en) A method of obtaining thiolcarbamates
CS188938B2 (en) Method of producing xanthene-9-spiro-4-piperidines
BG27915A3 (en) Method of obtaining of moenomyzin
SU677666A3 (en) Method of producing 7l-or extradiols
BG25518A3 (en) A method of obtaining xantain derivatives
BG25091A3 (en) A method of obtaining 7-acylamide-3-fluorcephalosporic compounds
CS189635B2 (en) Method of producing bromderivatives of 4-imido-thioazetidin-2-one
BG25081A3 (en) A method of obtaining isohinolines
BG25226A3 (en) A method of obtaining condensed pyridine-4-(3h)-oni
BG30776A3 (en) Method for obtaining of eburnamenine derivatives
BG31072A4 (en) Method for obtaining of sulphinylazetidinon
BG25212A3 (en) A method of obtaining substituted arylalcylamines